Financial news, mergers and acquisitions, partnerships, and alliances.
Theassay is designed for the rapid qualitative detection of platelet factor 4-heparin complex IgG antibodies associated with heparin-induced thrombocytopenia.
The two companies plan to secure required initial regulatory approvals in individual African territories before expanding to other areas in the region.
The Geneva-based clinical lab testing and medical diagnostic imaging services company expects to double its current revenues within three years.
The firm said that revenues for the third quarter is expected to be $63.1 million, which would be a 4 percent increase from the year-ago figure.
According to a presentation at the College of American Pathologists' annual meeting, around 62 percent of lab testing errors occur during the preanalytical phase.